OHSONG PHARM specializes in the import and export of pharmaceuticals to and from Japan.

OHSONG PHARM is a specialized company engaged in the import and export of pharmaceuticals between Korea and Japan, providing comprehensive services in development, approval, production, and marketing as a CDMO (Contract Development & Manufacturing Organization) and CMO (Contract Manufacturing Organization).
We operate a wholly-owned subsidiary in Japan, Brio Pharma, which specializes in pharmaceutical approvals and we are the first company in the country to secure a license through our efforts.